April 29 (Reuters) -
Annovis Bio said on Monday that its Alzheimer's treatment showed significantly higher improvement in cognition in Alzheimer's patients during a mid-stage trial. (Reporting by Christy Santhosh; Editing by Vijay Kishore)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 USD | +6.58% | +27.74% | -53.21% |
April 29 (Reuters) -
Annovis Bio said on Monday that its Alzheimer's treatment showed significantly higher improvement in cognition in Alzheimer's patients during a mid-stage trial. (Reporting by Christy Santhosh; Editing by Vijay Kishore)
1st Jan change | Capi. | |
---|---|---|
-53.21% | 97.75M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.61% | 21.6B | |
-12.38% | 22.31B | |
-6.77% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |